Anti-CD33 [hP67.6 (Gemtuzumab)]
Ab00283-13.0
ApplicationsFlow Cytometry, ImmunoFluorescence
Product group Antibodies
ReactivityHuman
TargetCD33
Overview
- SupplierAbsolute Antibody
- Product NameAnti-CD33 [hP67.6 (Gemtuzumab)]
- Delivery Days Customer7
- Antibody SpecificityRecognises human CD33.
- Application Supplier NoteA human IgG4 variant conjugated to derivative of the cytotoxic drug calicheamicin gamma 1, N-acetylcalicheamicin dimethyl hydrazide, has been used as a therapeutic against acute myeloid leukemia. This antibody may also be used in flow cytometry and immunofluorescence.
- ApplicationsFlow Cytometry, ImmunoFluorescence
- Applications SupplierFC; IF
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDhP67.6 (Gemtuzumab)
- Gene ID945
- Target nameCD33
- Target descriptionCD33 molecule
- Target synonymsCD33 antigen (gp67); CD33 molecule transcript; gp67; myeloid cell surface antigen CD33; p67; sialic acid-binding Ig-like lectin 3; SIGLEC3; SIGLEC-3
- HostHuman
- IsotypeIgG4
- Protein IDP20138
- Protein NameMyeloid cell surface antigen CD33
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteGemtuzumab was generated by huminization of the murine P67.6 clone, raised against CD33-transfected FMY9S5 cells of human origin. CD33 is a transmembrane receptor expressed on predominantly on cells of the myeloid lineage, but it can also be found on some lymphoid cells.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203